Radiation therapy use low in end-stage cancer

January 13, 2013
Radiation therapy use low in end-stage cancer
Although the overall use of radiation treatment among elderly end-stage cancer patients is low during their final month of life, many receive more than 10 days of treatment, according to a study published in the Jan. 1 issue of the Journal of Clinical Oncology.

(HealthDay)—Although the overall use of radiation treatment among elderly end-stage cancer patients is low during their final month of life, many receive more than 10 days of treatment, according to a study published in the Jan. 1 issue of the Journal of Clinical Oncology.

B. Ashleigh Guadagnolo, M.D., M.P.H., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues analyzed data on in the last month of life from 202,299 elderly patients (65 years and older) who had died from various cancers from 2000 to 2007.

The researchers found that 7.6 percent of patients had received radiation therapy in their last month of life, and its use was influenced by factors including race, gender, income, and hospice care. Of patients who received radiation therapy, 17.8 percent had received more than 10 days of treatment, which was more likely for non-Hispanic whites, those not receiving hospice care, and those treated in a freestanding rather than a hospital-associated facility. Among those receiving radiation therapy in the last month of life, the total costs of care in the last month of life was 32 percent lower among those who received .

"It is possible, on the basis of overall low percentage of patients who received radiotherapy in the last 30 days of life, that there is underuse of this modality in end-stage ," Guadagnolo and colleagues conclude. "However, dosing regimens that require dying patients to spend a significant proportion of their final days visiting a suite likely counters the overall aim of palliative care."

One author received funding from Helsinn.

Explore further: Ill, older patients who rely on emergency room often live final days in hospital, study finds

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Researchers discover underlying cause of myeloma

February 11, 2016

Yale Cancer Center researchers have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published Feb. 10 in the New England Journal of Medicine, could fundamentally change ...

Scientists find leukemia's surroundings key to its growth

February 10, 2016

Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous. The finding, published in ...

Study examines evolution of cancer

February 8, 2016

A novel Yale study answers age-old questions about how cancers spread by applying tools from evolutionary biology. The new insights will help scientists better understand the genetic origins of tumor metastases, and lead ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.